Publikasjoner - Farmakokinetikk

Avdeling for klinisk farmakologi

• Britz H, Hanke N, Volz AK, Spigset O, Schwab M, Eissing T, Wendl T, Frechen S. Lehr T. PBPK models for CYP1A2 DDI prediction: a modelling network of fluvoxamine, theophylline, caffeine, rifampicin and midazolam. CPT Pharmacometrics Syst Pharmacol 2019; 8: 296-307.
• Jönsson AK, Spigset O, Reis M. Serum concentrations of antipsychotic drugs in a naturalistic setting: Compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 2019; 41: 348-56.
• Chalabianloo F, Westin AA, Skogvoll E, Bramness JG, Spigset O. Methadone serum concentrations and influencing factors: a naturalistic observational study. Psychopharmacology 2019; e-pub ahead of print.
• Ausen K, Pleym H, Liu J, Hegstad S, Nordgård HB, Pavlovic I, Spigset O. Serum concentrations and pharmacokinetics of tranexamic acid after two means of topical administration in massive weight loss skin reducing surgery. Plastic Reconstr Surg 2019; 143; e1169-78.
• Helland A, Habib S, Ulvestad L, Spigset O. Systemic inflammation complicates the interpretation of therapeutic drug monitoring of risperidone. J Clin Psychopharmacol 2018; 38: 263-5.
• Castberg I, Westin AA, Skogvoll E, Spigset O. Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone and quetiapine. Acta Psychiatr Scand 2017, 136: 455-64.
• Helland A, Spigset O. Serum concentrations of paliperidone after administration of the long-acting injectable formulation. Ther Drug Monit 2017; 39: 659-62.
• Strømmen M, Helland A, Kulseng B, Spigset O. Increased bioavailability of methadone following sleeve gastrectomy – a planned case observation. Clin Ther 2016; 38: 1532-6.  

Sist oppdatert 22.03.2024